InvestorsHub Logo
Followers 0
Posts 2715
Boards Moderated 0
Alias Born 08/04/2003

Re: nolajo999 post# 12758

Monday, 07/03/2006 9:23:37 PM

Monday, July 03, 2006 9:23:37 PM

Post# of 45771
nolajo999, you certainly have shown effort in your post. Plenty of bold and bold+underline for investors to consider, including me.

With your bold AND underline the following, I considered the content... CDEX says, per your post nolajo999, "If we are unable to obtain customers and generate sufficient revenues to operate profitably, our business will not succeed."

Lets break it down...
Unable to obtain customers???

http://www.cdex-inc.com/pr.html

http://www.baxa.com/OnlineHelp/ValiMed_FAQ.asp


Unable to generate sufficient revenues to operate profitably? Well, revenue certainly seems to have at least STARTED to blossom and IF they generate the funding they seek, I suspect significant profits could be in our collective futures...

http://www.cdex-inc.com/pr/61606.html

CDEX Second Quarter Revenue Highest in Company's History

ValiMed Leads the Way

ROCKVILLE, Md.--(BUSINESS WIRE)--June 16, 2006--CDEX, Inc. (OTCBB:CEXI.OB - News) announced today that it recorded the highest quarterly revenue in the history of the company in the fiscal second quarter, ending April 30, 2006. Revenue was $351,038 as compared to $23,860 during the second fiscal quarter of 2005. The increase of $327,177 (or 1,371%) resulted from the delivery of ValiMed (TM) medication verification systems to Baxa Corporation. Baxa represents the CDEX ValiMed product line, exclusively in the USA and Canada.



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.